Lonza to lend manufacturing expertise and knowledge to Israeli biotechs 24-May-2022 By Jane Byrne Lonza has entered into a two-year agreement with Israel Biotech Fund (IBF) to support its portfolio of biotech companies.
Looking ahead: Israel sets up 2022 COVID-19 vaccine supply with Pfizer and Moderna 22-Apr-2021 By Rachel Arthur Israel has set up COVID-19 vaccine orders with Pfizer and Moderna this week: marking deals over the longer term for the two companies.
Israel’s health ministry has given Moderna’s COVID-19 vaccine the green light 05-Jan-2021 By Jane Byrne Israel’s Ministry of Health (MOH) has authorized the use of Moderna’s COVID-19 vaccine in that country.
Lonza centers itself in Israel for innovation in biologic manufacturing 20-Nov-2018 By Maggie Lynch Lonza Pharma & Biotech established itself in Israel, with the opening of a collaborative hub aiming to advance manufacturing technology for cell and gene therapy commercialization.
